9. Microvascular Complications and Foot Care

[31] Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease [J]. VASCULAR MEDICINE, 2002, 7 (01) : 35 - 43

[32] Gerstein HC, 2000, LANCET, V355, P253

[33] Pharmacologic Interventions for Painful Diabetic Neuropathy An Umbrella Systematic Review and Comparative Effectiveness Network Meta-analysis [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (09) : 639 - U138

[34] A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception - The Coronary Artery Risk Development in Young Adults (CARDIA) Study [J]. DIABETES, 2007, 56 (12) : 2990 - 2996

[35] Hooper P, 2012, CAN J OPHTHALMOL, V47, pS1, DOI 10.1016/j.jcjo.2011.12.025

[36] Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [J]. LANCET, 2010, 376 (9739) : 419 - 430

[37] Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes [J]. CIRCULATION, 2004, 110 (01) : 32 - 35

[38] HYPERGLYCEMIA AND MICROVASCULAR AND MACROVASCULAR DISEASE IN DIABETES [J]. DIABETES CARE, 1995, 18 (02) : 258 - 268

[39] Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria [J]. DIABETES CARE, 2014, 37 (01) : 226 - 234

[40] Identifying hepatic nuclear factor 1α mutations in children and young adults with a clinical diagnosis of type 1 diabetes [J]. DIABETES CARE, 2003, 26 (02) : 333 - 337

[31] Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease [J]. VASCULAR MEDICINE, 2002, 7 (01) : 35 - 43

[32] Gerstein HC, 2000, LANCET, V355, P253

[33] Pharmacologic Interventions for Painful Diabetic Neuropathy An Umbrella Systematic Review and Comparative Effectiveness Network Meta-analysis [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (09) : 639 - U138

[34] A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception - The Coronary Artery Risk Development in Young Adults (CARDIA) Study [J]. DIABETES, 2007, 56 (12) : 2990 - 2996

[35] Hooper P, 2012, CAN J OPHTHALMOL, V47, pS1, DOI 10.1016/j.jcjo.2011.12.025

[36] Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [J]. LANCET, 2010, 376 (9739) : 419 - 430

[37] Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes [J]. CIRCULATION, 2004, 110 (01) : 32 - 35

[38] HYPERGLYCEMIA AND MICROVASCULAR AND MACROVASCULAR DISEASE IN DIABETES [J]. DIABETES CARE, 1995, 18 (02) : 258 - 268

[39] Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria [J]. DIABETES CARE, 2014, 37 (01) : 226 - 234

[40] Identifying hepatic nuclear factor 1α mutations in children and young adults with a clinical diagnosis of type 1 diabetes [J]. DIABETES CARE, 2003, 26 (02) : 333 - 337